Abbott beats estimates, reports a 2.2% rise in Q1 sales
Abbott Laboratories on April 17 reported a 2.2% rise of $10 billion in its 2024 first-quarter sales which includes the impact of the anticipated decline in COVID-19 testing-related sales as compare...
Abbott Labs Stock Is Slipping. Disappointing Guidance Trumps a Strong Quarter.
Healthcare-products firm Abbott Laboratories' first-quarter earnings beat expectations, but second-quarter guidance was light.
Abbott beats quarterly profit estimates on strong medical device sales
Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday and raised the lower end of its forecast, as robust demand for medical procedures boosted sales of its devices, incl...
Markets Mixed as Q1 Earnings, Powell Control News Headlines
Wednesday morning brings us more Q1 earnings reports, including from Abbott Labs (ABT) and U.S. Bancorp (USB).
After Nearly A 20% Rise In Six Months Will Abbott Stock See Higher Levels Post Q1?
Abbott (NYSE: ABT) will report its Q1 2024 results on Wednesday, April 17. We expect the company to post revenue of $9.9 billion and earnings of $0.95 on a per share and adjusted basis, aligning wi...
3 Buy Rated Stocks to Consider as Earnings Approach
Several top-rated Zacks stocks are standing out before their first-quarter earnings report next week and here are three to consider.
Ahead of Abbott (ABT) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Evaluate the expected performance of Abbott (ABT) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics f...
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access to health-related products and...
Abbott (ABT) Faces Low Testing Demand, Currency Headwinds
Abbott's (ABT) core laboratory diagnostics business is gaining strength on the continued success of the Alinity suite of diagnostics instruments, along with a broad test menu offering.
Abbott (ABT) Receives FDA's Approval for the TriClip TEER System
Abbott (ABT) receives FDA nod for TriClip, a first-of-its-kind device to repair a leaky tricuspid heart valve.
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm empl...
Abbott's (ABT) i-STAT TBI Cartridge Receives FDA Approval
Abbott's (ABT) i-STAT Alinity instrument uses whole blood to help assess patients with a suspected mild traumatic brain injury or concussion.
US FDA approves Abbott's heart valve repair device
Abbott Laboratories said on Tuesday the U.S. FDA has approved its heart valve repair device designed for patients at risk of complications or death during open-heart surgeries.
Abbott (ABT) Declines More Than Market: Some Information for Investors
Abbott (ABT) concluded the recent trading session at $112.09, signifying a -1.38% move from its prior day's close.
3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List
As the number of grey-haired people rises worldwide, investors need to notice the strong-buy healthcare stocks. The need for healthcare will grow as the number of people aged 60 years and older do...
Related Companies